Share on :

Asset Summary

Daily Performance Report for LLY ETF: Dec 26, 2024

Summary: The day started with LLY ETF opening at $790.42 and closing at $793.68. The ETF showed resilience throughout the day, with the highest price observed at $794.25 and the lowest at $790.42. The underlying asset had a trading range of $3.83 Overall, it was a positive trading day for LLY ETF, reflecting investor optimism and market activity.

Change in Closing Price: There was a net increase of $3.26 or 0.41% in the closing price from the opening to the closing price over the day.

Volume Analysis: Trading volume for LLY ETF was 3,591 units during Dec 26, 2024, indicating active market participation and investor interest.

Opening Price: The day started at $790.42.

Highest Price: The highest price observed during the day was $794.25.

Lowest Price: The lowest price observed during the day was $790.42.

Closing Price: The day ended at $793.68.

Asset Performance Metrics and Risk Characteristics:

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. By using various technical indicators and chart patterns, investors can gain insights into market trends, price momentum, and potential turning points. This section delves into essential technical metrics, including moving averages, pivot points, and other indicators that provide a snapshot of an asset's current technical stance. Analyzing these indicators helps investors identify entry and exit points, assess market sentiment, and refine their trading strategies. Explore the following technical analysis data to understand the asset's performance dynamics and make better-informed decisions.

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Transform Your LLY Trading Now

Elevate your trading strategy with Rank My Trade’s sophisticated tools for LLY. Our system integrates cutting-edge technology and expert analysis to support your investment goals. Transform your trading strategy now and explore the benefits of advanced trading now!

Get Advanced Analysis Now

Frequently Asked Questions

Stay updated through financial news websites, press releases, and Eli Lilly’s official communications.

For recent achievements, check their website for press releases and updates on new drug approvals and partnerships.

Eli Lilly engages in global health initiatives, providing access to medicines and supporting healthcare improvements worldwide.

You can access Eli Lilly’s financial statements on the investor relations section of their official website.

Analyst ratings and opinions can be found on investment research platforms and major financial news sites.

Factors include clinical trial results, regulatory approvals, and overall market conditions in the pharmaceutical industry.

The outlook depends on pipeline successes, regulatory changes, and overall market conditions impacting the pharmaceutical industry.

Market capitalization changes frequently; check financial platforms for the latest information on LLY.

Eli Lilly invests heavily in R&D to innovate and bring new therapies to market, focusing on unmet medical needs.

Key products include insulin therapies, cancer treatments, and medications for depression and autoimmune diseases.

Enhance Your LLY Trading Now

Experience the future of trading with Rank My Trade Online. Our advanced system delivers in-depth analysis and insights for LLY, utilizing state-of-the-art technical tools and strategies. Enhance your market performance today and see how we can elevate your trading results!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. RankMyTrade (RMT) has not independently verified this data and does not guarantee its accuracy. The information and calculations provided by RankMyTrade are for educational and informational purposes only and should not be construed as financial or investment advice.

With any investment, your capital is at risk. The value of your portfolio go down as well as up. Past performance is no guarantee of future results. By using this website, you accept our Terms of Service, Privacy Policy, and Payment Agreement.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind. Unless otherwise noted, RankMyTrade and its affiliates are not partners, affiliates, or licensees of these companies.

Supported Assets & ETFs